Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse
Clinical trial NCT01068782 · TERMINATED
Trial details
- NCT number
- NCT01068782
- Sponsor
- Exelixis
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-05-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.